Our research is oriented toward improving the lives of children with blood disorders and childhood cancer, while working toward future improved treatments and outcomes. We have active programs in clinical, clinical epidemiologic and laboratory research.
Since 1987, we have been directly involved in the advancement of care through multi-institutional cooperative group clinical trials through the Children's Oncology Group.
We participate in the Connecticut State Board of Health Newborn Hemoglobinopathy Screening Program and the New England Sickle Cell Consortium. Our physicians conduct research on the effects of cancer treatment, including the late effects of childhood cancer treatment, neurocognitive function in children treated for leukemia and the risk of subsequent malignancies among children treated for childhood cancer. We also conduct clinical trials on treatments for
Visit yalestudies.org to view available clinical trials or learn more about clinical research at Yale.